News Archive
Displaying the 10 most recent press releases...
Thursday, August 19, 2010
EntreMed Receives NASDAQ Listing Rule 5550(b)(2) Determination Letter
Monday, August 16, 2010
EntreMed Reports Second Quarter 2010 Financial Results
Tuesday, July 20, 2010
EntreMed Regains Compliance With NASDAQ Minimum Bid Price Rule
Tuesday, July 13, 2010
EntreMed’s ENMD-2076 Demonstrates Significant Anti-Cancer Activity in Multiple Myeloma Preclinical Models
Wednesday, June 30, 2010
EntreMed Announces Reverse Stock Split
Wednesday, June 2, 2010
ENMD-2076 Demonstrates Preclinical Antitumor Activity in Colorectal Cancer
Tuesday, May 18, 2010
EntreMed Provides Corporate Update and Reports First Quarter 2010 Financial Results
Wednesday, May 12, 2010
EntreMed Announces First Quarter 2010 Update Call
Tuesday, May 11, 2010
EntreMed Initiates Second Site in ENMD-2076 Phase 2 Ovarian Cancer Study
Friday, April 16, 2010
EntreMed Raises Additional $3 Million to Further Support Clinical Development of ENMD-2076 in Ovarian Cancer